ambossIconambossIcon

Granuloma inguinale

Last updated: February 4, 2025

Summarytoggle arrow icon

Granuloma inguinale is a sexually transmitted bacterial disease caused by Klebsiella granulomatis. It is seen most commonly in sexually active individuals between 20 and 40 years of age. Clinically, granuloma inguinale manifests with one or more genital nodules that develop into red, painless ulcers. The regional lymph nodes are typically spared. Diagnosis of granuloma inguinale is based primarily on clinical findings and is confirmed through the detection of Donovan bodies (intracytoplasmic macrophages containing bacteria) in ulcer smears or biopsies. Antibiotic therapy (preferably with azithromycin) should be continued for at least 3 weeks and until the ulcers have completely healed.

Epidemiologytoggle arrow icon

  • Prevalence: endemic to tropical and subtropical countries
  • Incidence: rare (< 100 cases annually) in the US
  • Age range: 20–40 years

Epidemiological data refers to the US, unless otherwise specified.

Etiologytoggle arrow icon

Clinical featurestoggle arrow icon

  • Incubation period: highly variable (1 day to 1 year); median time ∼ 50 days
  • Clinical features [1][2]

Granuloma inguinale (Klebsiella granulomatis) should not be mistaken for lymphogranuloma inguinale (Chlamydia trachomatis serotype L1–L3), which is commonly known as lymphogranuloma venereum!

Diagnosistoggle arrow icon

  • Microscopic examination of fluid, tissue scrapings, or biopsy of the genital lesion: The presence of Donovan bodies on microscopy confirms the diagnosis.
    • Intracytoplasmic cysts filled with deeply staining , safety-pin shaped bodies within macrophages (Pud cells)
  • Molecular assays : Can be considered to identify the causative pathogen if Donovan bodies were not detected on microscopy.
  • K. granulomatis is difficult to culture.

HIV testing is recommended for all patients with granuloma inguinale. [1]

Differential diagnosestoggle arrow icon

The differential diagnoses listed here are not exhaustive.

Treatmenttoggle arrow icon

Complicationstoggle arrow icon

We list the most important complications. The selection is not exhaustive.

Icon of a lock3 free articles left this month

Start a 5-day free trial or sign up for unlimited access.
 Evidence-based content, created and peer-reviewed by clinicians. Read the disclaimer